News

PROFID AT ESC 2023

This year, PROFID had a marked presence at the European Society of Cardiology 2022 Congress, the world’s largest cardiovascular congress, during the session “Latest Science in Arrhythmias”. Project coordinator Dr. Nikolaos Dagres of the Leipzig Heart Institute presented the final results of the PROFID analysis.

Interview – THE START OF THE PROFID CLINICAL TRIAL

The PROFID trial aims to reassess the role of routine prophylactic ICD implantation in patients with reduced LVEF ≤ 35% after myocardial infarction under contemporary OMT and is designed to be as close to routine clinical care as possible. The start of the PROFID clinical trial is a huge milestone.

PROFID AT EHRA 2023

We had the great opportunity to present PROFID to world-leading cardiology experts at the EHRA Congress 2023 in Barcelona. Gerhard Hindricks gave a presentation about the “Generation of novel randomized evidence for the role of primary prevention ICD under contemporary treatment”, in which he showed once again why the PROFID project is urgently needed for the improvement of patient care.

Interview – THE PROFID CLINICAL TRIAL

After extensive 2.5 years, the PROFID data analysis has been completed. The results, which were presented at the ESC Congress 2022 in Barcelona, have significant implications for the setup of the randomized trial programme. We are currently finalizing an updated design of the PROFID clinical trial, in order to start the submissions to the Ethics Committees at the beginning of 2023.

CONDUCTING THE PROFID TRIAL

The Clinical Research Institute in Munich, Germany, is a full-service Contract Research Organisation (CRO) specialized in large international, commercial and non-commercial (academic) clinical studies in Europe covering both, drug trials and medical device studies.

PROFID at ESC 2022

This year, PROFID had a marked presence at the European Society of Cardiology 2022 Congress, the world’s largest cardiovascular congress, during the session “Latest Science in Arrhythmias”. Project coordinator Dr. Nikolaos Dagres of the Leipzig Heart Institute presented the final results of the PROFID analysis.

ESC/ EHRA – engaged to reduce the burden of cardiovascular diseases

The European Association of Cardiology (ESC) is an independent, non-profit organisation and represents more than 95,000 decision-makers and healthcare professionals in the field of cardiology. The ESC acts in the interest of patients by providing cardiologists with the support and tools they need to deliver the best possible care.